Efficient production of erythroid, megakaryoid and myeloid cells, using single cell-derived iPSC colony differentiation
Preprint
Abstract
Hematopoietic differentiation of human induced pluripotent stem cells (iPSCs) provide opportunities not only for fundamental research and disease modelling/drug testing but also for large-scale production of blood effector cells for future clinical application. Although there are multiple ways to differentiate human iPSCs towards hematopoietic lineages, there is a need to develop reproducible and robust protocols. Here we introduce an efficient way to produce three major blood cell types using a standardized differentiation protocol that starts with a single hematopoietic initiation step. This system is feeder-free, avoids EB-formation, starts with a hematopoietic initiation step based on a novel single cell-derived iPSC colony differentiation and produces multi-potential progenitors within 8-10 days. Followed by lineage-specific growth factor supplementation these cells can be matured into well characterized erythroid, megakaryoid and myeloid cells with high-purity, without transcription factor overexpression or any kind of pre-purification step. This standardized differentiation system provides a simple platform to produce specific blood cells in a reproducible manner for hematopoietic development studies, disease modelling, drug testing and the potential for future therapeutic applications. Highlights: Efficient hematopoietic differentiation from single cell-derived iPSC colonies Reproducible feeder-free, monolayer differentiation system independent of iPSC line Production of erythroid, megakaryoid and myeloid cells with high-purity Platform for hematopoietic developmental research and future clinical applicationKeywords
All Related Versions
- Published version: Stem Cell Research, 29, 232.
This publication has 63 references indexed in Scilit:
- Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X 0 -Linked, AR22 0 - and AR47 0 - Chronic Granulomatous DiseasesBioResearch Open Access, 2014
- Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem CellsStem Cell Reports, 2014
- Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of originHaematologica, 2014
- Actin-Myosin Contractility Is Responsible for the Reduced Viability of Dissociated Human Embryonic Stem CellsCell Stem Cell, 2010
- Toll-like receptor–induced reactivity and strongly potentiated IL-8 production in granulocytes mobilized for transfusion purposesBlood, 2010
- Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell–derived lin–CD34+CD43+CD45+ progenitorsJournal of Clinical Investigation, 2009
- Hematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem CellsStem Cells, 2009
- Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globinBlood, 2006
- The glucocorticoid receptor is required for stress erythropoiesisGenes & Development, 1999
- In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patientsBritish Journal of Cancer, 1988